Top

Obesity Surgery

Published in:

01-12-2020 | Sleeve Gastrectomy | Original Contributions

An Opioid-Sparing Protocol Improves Recovery Time and Reduces Opioid Use After Laparoscopic Sleeve Gastrectomy

Authors: Benjamin Pardue, Austin Thomas, Jake Buckley, William J. Suggs

Published in: Obesity Surgery | Issue 12/2020

Abstract

Purpose

The current literature is sparse on post discharge pain management for bariatric surgical patients. This study aimed to determine if an opioid-sparing protocol could decrease opioid use during the postoperative period (hospital to home).

Materials and Methods

In this retrospective cohort study, we implemented an opioid-sparing protocol in January 2018, for patients undergoing laparoscopic sleeve gastrectomy (LSG) at our institution. We compared recovery time, pain scores (in hospital and at home), and perioperative opioid use between the historic control group (February 2017 to December 2017) and the opioid-sparing group (January 2018 to December 2018). A p value of < .05 was considered statistically significant.

Results

The study included 400 patients (200 in each group), and 165 participated in the phone survey. Baseline characteristics were similar, except the control group had a higher body mass index and body weight. The average recovery time was significantly shorter in the opioid-sparing group (18.9 versus 35.3 days, P = .043). There was no significant difference in mean postoperative pain scores in the hospital or at home. The opioid-sparing group required significantly fewer opioids postoperatively (10.4 versus 16.1 morphine milligram equivalents, P < .001). Only 1 out of the 200 patients in the opioid-sparing arm requested an opioid prescription after discharge.

Conclusion

Implementation of an opioid-sparing protocol improved recovery time and reduced postoperative opioid use in the hospital and after discharge without changing perceived pain in patients undergoing LSG.

Available only for authorised users

Hill MV, McMahon ML, Stucke RS, et al. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709–14. https://doi.org/10.1097/SLA.0000000000001993.CrossRefPubMed

Bicket MC, Long JJ, Pronovost PJ, et al. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152(11):1066–71. https://doi.org/10.1001/jamasurg.2017.0831.CrossRefPubMedPubMedCentral

Friedman DT, Ghiassi S, Hubbard MO, et al. Postoperative opioid prescribing practices and evidence-based guidelines in bariatric surgery. Obes Surg. 2019;29(7):2030–6. https://doi.org/10.1007/s11695-019-03821-8.CrossRefPubMed

Chen EY, Marcantonio A, Tornetta 3rd P. Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge. JAMA Surg. 2018;153(2):174859. https://doi.org/10.1001/jamasurg.2017.4859.CrossRef

Brethauer SA, Grieco A, Fraker T, et al. Employing enhanced recovery goals in bariatric surgery (ENERGY): a national quality improvement project using the metabolic and bariatric surgery accreditation and quality improvement program. Surg Obes Relat Dis. 2019;15(11):1977–89. https://doi.org/10.1016/j.soard.2019.08.024.CrossRefPubMed

Ahmed OS, Rogers AC, Bolger JC, et al. Meta-analysis of enhanced recovery protocols in bariatric surgery. J Gastrointest Surg. 2018;22(6):964–72. https://doi.org/10.1007/s11605-018-3709-x.CrossRefPubMed

Thorell A, MacCormick AD, Awad S, et al. Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40(9):2065–83. https://doi.org/10.1007/s00268-016-3492-3.CrossRefPubMed

Ng JJ, Leong WQ, Tan CS, et al. A multimodal analgesic protocol reduces opioid-related adverse events and improves patient outcomes in laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(12):3075–81. https://doi.org/10.1007/s11695-017-2790-7.CrossRefPubMed

Smith ME, Lee JS, Bonham A, et al. Effect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery. Surg Endosc. 2019;33(8):2649–56. https://doi.org/10.1007/s00464-018-6542-0.CrossRefPubMed

10.

King WC, Chen JY, Belle SH, et al. Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017;13(8):1337–46. https://doi.org/10.1016/j.soard.2017.04.003.CrossRefPubMedPubMedCentral

11.

Horsley RD, Vogels ED, McField DAP, et al. Multimodal postoperative pain control is effective and reduces opioid use after laparoscopic roux-en-Y gastric bypass. Obes Surg. 2019;29(2):394–400. https://doi.org/10.1007/s11695-018-3526-z.CrossRefPubMed

12.

Saurabh S, Smith JK, Pedersen M, et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11(2):424–30. https://doi.org/10.1016/j.soard.2014.09.017.CrossRefPubMed

13.

Song K, Melroy MJ, Whipple OC. Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients. Pharmacotherapy. 2014;34(Suppl 1):14S–21S. https://doi.org/10.1002/phar.1517.CrossRefPubMed

14.

Strode MA, Sherman W, Mangieri CW, et al. Randomized trial of OFIRMEV versus placebo for pain management after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(4):772–7. https://doi.org/10.1016/j.soard.2015.08.512.CrossRefPubMed

15.

Ziemann-Gimmel P, Hensel P, Koppman J, et al. Multimodal analgesia reduces narcotic requirements and antiemetic rescue medication in laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2013;9(6):975–80. https://doi.org/10.1016/j.soard.2013.02.003.CrossRefPubMed

16.

Bamgbade OA, Oluwole O, Khaw RR. Perioperative analgesia for fast-track laparoscopic bariatric surgery. Obes Surg. 2017;27(7):1828–34. https://doi.org/10.1007/s11695-017-2562-4.CrossRefPubMed

17.

King AB, Spann MD, Jablonski P, et al. An enhanced recovery program for bariatric surgical patients significantly reduces perioperative opioid consumption and postoperative nausea. Surg Obes Relat Dis. 2018;14(6):849–56. https://doi.org/10.1016/j.soard.2018.02.010.CrossRefPubMed

18.

Mark J, Argentieri DM, Gutierrez CA, et al. Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery. JAMA Netw Open. 2018;1(8):e185452. https://doi.org/10.1001/jamanetworkopen.2018.5452.CrossRefPubMedPubMedCentral

19.

Howard R, Waljee J, Brummett C, et al. Reduction in opioid prescribing through evidence-based prescribing guidelines. JAMA Surg. 2018;153(3):285–7. https://doi.org/10.1001/jamasurg.2017.4436.CrossRefPubMed

20.

Overton HN, Hanna MN, Bruhn WE, et al. Opioid-prescribing guidelines for common surgical procedures: an expert panel consensus. J Am Coll Surg. 2018;227(4):411–8. https://doi.org/10.1016/j.jamcollsurg.2018.07.659.CrossRefPubMedPubMedCentral

21.

Wick EC, Grant MC, Wu CL. Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: a review. JAMA Surg. 2017;152(7):691–7. https://doi.org/10.1001/jamasurg.2017.0898.CrossRefPubMed

22.

Stowers MD, Lemanu DP, Hill AG. Health economics in enhanced recovery after surgery programs. Can J Anaesth. 2015;62(2):219–30. https://doi.org/10.1007/s12630-014-0272-0.CrossRefPubMed

23.

US Drug Enforcement Agency (DEA). Schedules of controlled substances: placement of tramadol into schedule IV. Published July 2, 2014. Accessed February 7, 2020 at https://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0702.htm.

24.

Hickman SR, Mathieson KM, Bradford LM, et al. Randomized trial of oral versus intravenous acetaminophen for postoperative pain control. Am J Health Syst Pharm. 2018;75(6):367–75. https://doi.org/10.2146/ajhp170064.CrossRefPubMed

25.

Jibril F, Sharaby S, Mohamed A, et al. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015;68(3):238–47. https://doi.org/10.4212/cjhp.v68i3.1458.CrossRefPubMedPubMedCentral

Title: An Opioid-Sparing Protocol Improves Recovery Time and Reduces Opioid Use After Laparoscopic Sleeve Gastrectomy
Authors: Benjamin Pardue
Austin Thomas
Jake Buckley
William J. Suggs
Publication date: 01-12-2020
Publisher: Springer US
Keywords: Sleeve Gastrectomy
Paracetamol
Bariatric Surgery
Opioids
Bariatric Surgery
Opioids
Morphine
Published in: Obesity Surgery / Issue 12/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-020-04980-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

An Opioid-Sparing Protocol Improves Recovery Time and Reduces Opioid Use After Laparoscopic Sleeve Gastrectomy

Abstract

Purpose

Materials and Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2020

The Effectiveness and Feasibility of Laparoscopic Re-sleeve Gastrectomy

Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study

Bariatric Surgery Impact on Reproductive Hormones, Semen Analysis, and Sperm DNA Fragmentation in Men with Severe Obesity: Prospective Study

Relapse of Diabetes After Roux-en-Y Gastric Bypass for Patients With Obesity: 12 Years Follow-up Study

Silent Gastroesophageal Reflux Disease in Patients with Morbid Obesity Prior to Primary Metabolic Surgery

Single-Incision Transumbilical Laparoscopic Sleeve Gastrectomy with a Stomach Retractor in 20 Superobese Patients—a Video Vignette